» Articles » PMID: 29399086

COPB2 Suppresses Cell Proliferation and Induces Cell Cycle Arrest in Human Colon Cancer by Regulating Cell Cycle-related Proteins

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2018 Feb 6
PMID 29399086
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Coat proteins (COPs), including the major types clathrin, COPI and COPII, play a considerable role in intracellular transport by initiating the formation of transport vesicles. Coatomer protein complex subunit β2 (COPB2) is one of the seven subunits that make up a COPI complex. In the present study, we found that COPB2 was highly expressed in human colon cancer specimens. However, to date, there have been no reports describing the functions of COPB2 in human colon cancer cells. In this study, we analyzed the functions of COPB2 in the proliferation and cell cycle arrest of human RKO and HCT116 colon cancer cells by using lentivirus-mediated RNAi infection. Our results demonstrated that the silencing of COPB2 could inhibit the proliferation and colony formation abilities of RKO and HCT116 cells. Furthermore, measurement of cell cycle distribution indicated that the downregulation of COPB2 could induce G0/G1 or S phase cell cycle arrest by regulating cell cycle-related proteins. In conclusion, our results suggest that COPB2 plays a key role in the proliferation and cell cycle progression of human RKO and HCT116 colon cancer cells, thus indicating that COPB2 might be a potential therapeutic target for the treatment of human colon cancer.

Citing Articles

Identification of Translocon-associated Protein Delta as An Oncogene in Human Colorectal Cancer Cells.

Amarakoon D, Lee W, Peng J, Lee S J Cancer Prev. 2025; 29(4):175-184.

PMID: 39790222 PMC: 11706732. DOI: 10.15430/JCP.24.014.


Molecular mechanisms of microRNA-216a during tumor progression.

Hamidi A, Taghehchian N, Zangouei A, Akhlaghipour I, Maharati A, Basirat Z Cancer Cell Int. 2023; 23(1):19.

PMID: 36740668 PMC: 9899407. DOI: 10.1186/s12935-023-02865-2.


Identification of Transferrin Receptor 1 (TfR1) Overexpressed in Lung Cancer Cells, and Internalization of Magnetic Au-CoFeO Core-Shell Nanoparticles Functionalized with Its Ligand in a Cellular Model of Small Cell Lung Cancer (SCLC).

Villalobos-Manzo R, Rios-Castro E, Hernandez-Hernandez J, Oza G, Medina M, Tapia-Ramirez J Pharmaceutics. 2022; 14(8).

PMID: 36015341 PMC: 9413248. DOI: 10.3390/pharmaceutics14081715.


Characterization of Butyrate-Resistant Colorectal Cancer Cell Lines and the Cytotoxicity of Anticancer Drugs against These Cells.

Nittayaboon K, Leetanaporn K, Sangkhathat S, Roytrakul S, Navakanitworakul R Biomed Res Int. 2022; 2022:6565300.

PMID: 35909471 PMC: 9325644. DOI: 10.1155/2022/6565300.


Upregulation of COPB2 Promotes Prostate Cancer Proliferation and Invasion Through the MAPK/TGF-β Signaling Pathway.

Feng Y, Sun C, Zhang L, Wan H, Zhou H, Chen Y Front Oncol. 2022; 12:865317.

PMID: 35600351 PMC: 9120942. DOI: 10.3389/fonc.2022.865317.


References
1.
Wang D, Sun S, Yu Y, Wu W, Yang S, Tan J . Suppression of SCIN inhibits human prostate cancer cell proliferation and induces G0/G1 phase arrest. Int J Oncol. 2013; 44(1):161-6. DOI: 10.3892/ijo.2013.2170. View

2.
Bie C, Liu X, Cao M, Huang Q, Tang H, Wang M . Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expression. Oncotarget. 2016; 7(48):79305-79318. PMC: 5346715. DOI: 10.18632/oncotarget.13027. View

3.
Brenner H, Kloor M, Pox C . Colorectal cancer. Lancet. 2013; 383(9927):1490-1502. DOI: 10.1016/S0140-6736(13)61649-9. View

4.
Soritau O, Tomuleasa C, Aldea M, Petrushev B, Susman S, Gheban D . Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas. J BUON. 2011; 16(2):282-9. View

5.
Arora N, Gupta A, Paul Singh P . Biological agents in gastrointestinal cancers: adverse effects and their management. J Gastrointest Oncol. 2017; 8(3):485-498. PMC: 5506281. DOI: 10.21037/jgo.2017.01.07. View